Navigation Links
Dow AgroSciences Confirms Efficacy of Zinc Finger Nucleases for Precise Genome Modification in Maize
Date:4/29/2009

Breakthrough technology could transform agricultural advancement

Indianapolis (PRWEB) April 29, 2009 - Scientists at Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE:DOW), have demonstrated insertion of a gene for a herbicide-tolerant trait to a specific, pre-determined location in the maize genome confirming that precise modification is practical and feasible, according to new research published in the advanced online edition of the journal Nature.

The new development, EXZACT™ Precision Technology, is based on utilizing proprietary Zinc-Finger Nucleases™ (ZFNs) for trait engineering and establishes a new industry standard to enhance global crop production through precise genetic modification in plant species. It is the only technology capable of specifically targeting any DNA sequence, thereby providing flexibility and versatility in genetic research and enabling developers to add, delete or edit genes in plants. EXZACT™ Precision Technology enhances the efficient discovery and development of novel traits and solutions for crop production.

"EXZACT Precision Technology has the potential to re-define the future of agriculture, driving productivity gains globally and greatly enhancing sustainability in a major food crop such as maize. We have proven this technology and modified the crop to enhance nutritional benefits and herbicide tolerance which will produce real benefits to farmers and consumers over time," said Jerome Peribere, President and CEO of Dow AgroSciences. "This breakthrough illustrates Dow AgroSciences commitment to lead innovation in agriculture."

The addition of a herbicide tolerance gene was targeted to disrupt ZmIPK1 in corn, an especially attractive choice because ZmIPK1 encodes an enzyme that is involved in biosynthesis of phytate, a component of feed corn that is particularly difficult to digest for certain animals like pigs and chickens causing excess phosphate presence in the environment. Research results confirmed the herbicide tolerance gene was inserted into the specified domain without random integration of DNA from the donor or the ZFN. Dow AgroSciences research also proved that the herbicide tolerance gene was transmitted to the next generation via normal reproduction. Finally, the research illustrated the dual benefits of herbicide tolerance and reduced phytate levels.

"Conventional agricultural biotechnology has been a laborious, time-consuming and unpredictable undertaking," said Vipula Shukla, project leader for EXACT at Dow AgroSciences. "However, results of the EXZACT Precision Technology show that ZFNs can be utilized in any plant species amenable to DNA delivery, including commodity crops, vegetables, ornamentals, trees and biomass crops. This establishes a new, rapid and efficient strategy for precise plant genetic modification in basic science and agricultural applications. Additionally, it provides a new and efficient path to market, reducing the cost and complexity of product development."

Dow AgroSciences is making EXZACT Precision Technology available and accessible to all segments of the industry through collaboration.

A Research and Commercial License Agreement between Dow AgroSciences and Richmond, Calif. based Sangamo BioSciences Inc. was initiated in October 2005. The agreement provided Dow AgroSciences with access to Sangamo's proprietary zinc finger DNA-binding protein (ZFP) technology for the development of products in plants and plant cell cultures. Sangamo BioSciences and Dow AgroSciences worked together on the successful research program targeted on plants, and Dow AgroSciences exercised the commercial license in June 2008.

For more information, please visit www.exzactprecisiontechnology.com.

About Dow AgroSciences- Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion. Learn more at www.dowagro.com.

EXZACT™ Precision Technology is a trademark of Dow AgroSciences LLC
ZFN™ is a trademark of Sangamo Biosciences Inc.

###

Read the full story at http://www.prweb.com/releases/2009/04/prweb2373454.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Dow AgroSciences Receives Approval for New Technology to Control Cotton Pests in Brazil
2. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
3. Dow AgroSciences Delivering Beyond Expectations
4. Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil
5. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
6. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
7. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
8. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
9. Dow AgroSciences Success Presented to Wall Street
10. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
11. NIH News Confirms Trend in Stem Cell Storage Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Dow AgroSciences Confirms Efficacy of Zinc Finger Nucleases for Precise Genome Modification in Maize
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... ... At its national board meeting in North Carolina, ARCS® Foundation President ... and Astronomy, has been selected for membership in ARCS Alumni Hall of Fame ... Prize in Fundamental physics for the discovery of the accelerating expansion of the universe, ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... the medical journal, Epilepsia, Brain Sentinel’s SPEAC® System which uses the surface ... detecting generalized tonic-clonic seizures (GTCS) using surface electromyography (sEMG). The prospective multicenter ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C ... software to perform Hi-C metagenome deconvolution using their own facilities, supplementing the ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
Breaking Biology News(10 mins):